Vasopressin secretion control: central neural pathways, neurotransmitters and effects of drugs.
Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
Endocrinology and Metabolic Diseases, University of Bari "Aldo Moro", Bari, Italy.
Michele
M
Iovino
Edoardo
E
Guastamacchia
Vito Angelo
VA
Giagulli
Brunella
B
Licchelli
Vincenzo
V
Triggiani
D000818:Animals; D006801:Humans; D009434:Neural Pathways / Q000187:drug effects* / Q000502:physiology; D018377:Neurotransmitter Agents / Q000494:pharmacology* / Q000502:physiology*; D009994:Osmolar Concentration; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D010904:Pituitary Gland, Posterior / Q000187:drug effects / Q000502:physiology; D017483:Receptors, Vasopressin / Q000502:physiology*; D014667:Vasopressins / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D014882:Water-Electrolyte Balance
D018377:Neurotransmitter Agents; D017483:Receptors, Vasopressin; D014667:Vasopressins